Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Work In Process: 2022-2025

Historic Work In Process for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $26,695.

  • InMed Pharmaceuticals' Work In Process rose 2192.09% to $422,798 in Q3 2025 from the same period last year, while for Sep 2025 it was $422,798, marking a year-over-year increase of 2192.09%. This contributed to the annual value of $26,695 for FY2025, which is 13.38% down from last year.
  • Per InMed Pharmaceuticals' latest filing, its Work In Process stood at $26,695 for FY2025, which was down 13.38% from $30,817 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Work In Process registered a high of $1.7 million during FY2022, and its lowest value of $26,695 during FY2025.
  • Its 3-year average for Work In Process is $190,542, with a median of $30,817 in 2024.
  • Data for InMed Pharmaceuticals' Work In Process shows a maximum YoY tumbled of 94.01% (in 2024) over the last 5 years.
  • InMed Pharmaceuticals' Work In Process (Yearly) stood at $1.7 million in 2022, then crashed by 70.19% to $514,113 in 2023, then slumped by 94.01% to $30,817 in 2024, then fell by 13.38% to $26,695 in 2025.